vs
DocGo Inc.（DCGO）与P3 Health Partners Inc.（PIII）财务数据对比。点击上方公司名可切换其他公司
P3 Health Partners Inc.的季度营收约是DocGo Inc.的5.1倍（$384.8M vs $74.9M）。P3 Health Partners Inc.净利率更高（-19.6% vs -190.0%，领先170.3%）。P3 Health Partners Inc.同比增速更快（3.8% vs -38.0%）。过去两年P3 Health Partners Inc.的营收复合增速更高（-0.5% vs -37.5%）
DocGo Inc.是总部位于美国的移动医疗及按需医疗服务提供商，业务覆盖上门急诊、检测诊断、远程问诊、企业健康管理等领域，服务对象涵盖个人患者、医疗机构、企业客户及公共部门，主要市场为北美地区。
P3 Health Partners Inc.是一家总部位于美国的人口健康管理与价值型医疗服务企业，与基层医疗机构及医疗系统合作，为包括联邦医保优势计划参保者在内的人群提供协同优质医疗服务，致力于提升诊疗效果、降低不必要的医疗开支。
DCGO vs PIII — 直观对比
营收规模更大
PIII
是对方的5.1倍
$74.9M
营收增速更快
PIII
高出41.8%
-38.0%
净利率更高
PIII
高出170.3%
-190.0%
两年增速更快
PIII
近两年复合增速
-37.5%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $74.9M | $384.8M |
| 净利润 | $-142.3M | $-75.5M |
| 毛利率 | — | — |
| 营业利润率 | -139.6% | -40.0% |
| 净利率 | -190.0% | -19.6% |
| 营收同比 | -38.0% | 3.8% |
| 净利润同比 | -1761.4% | -28.8% |
| 每股收益（稀释后） | $-1.36 | $-23.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DCGOPIII
| Q4 25 | $74.9M | $384.8M | ||
| Q3 25 | $70.8M | $345.3M | ||
| Q2 25 | $80.4M | $355.8M | ||
| Q1 25 | $96.0M | $373.2M | ||
| Q4 24 | $120.8M | $370.7M | ||
| Q3 24 | $138.7M | $362.1M | ||
| Q2 24 | $164.9M | $379.2M | ||
| Q1 24 | $192.1M | $388.5M |
净利润DCGOPIII
| Q4 25 | $-142.3M | $-75.5M | ||
| Q3 25 | $-27.8M | $-31.6M | ||
| Q2 25 | $-11.2M | $-20.4M | ||
| Q1 25 | $-9.4M | $-20.5M | ||
| Q4 24 | $-7.6M | $-58.6M | ||
| Q3 24 | $5.5M | $-46.5M | ||
| Q2 24 | $6.5M | $-12.0M | ||
| Q1 24 | $11.2M | $-18.7M |
营业利润率DCGOPIII
| Q4 25 | -139.6% | -40.0% | ||
| Q3 25 | -59.3% | -12.8% | ||
| Q2 25 | -21.7% | -9.6% | ||
| Q1 25 | -14.6% | -10.2% | ||
| Q4 24 | -6.2% | -37.4% | ||
| Q3 24 | 7.3% | -29.5% | ||
| Q2 24 | 6.2% | -8.3% | ||
| Q1 24 | 8.3% | -11.3% |
净利率DCGOPIII
| Q4 25 | -190.0% | -19.6% | ||
| Q3 25 | -39.2% | -9.1% | ||
| Q2 25 | -13.9% | -5.7% | ||
| Q1 25 | -9.8% | -5.5% | ||
| Q4 24 | -6.3% | -15.8% | ||
| Q3 24 | 4.0% | -12.8% | ||
| Q2 24 | 4.0% | -3.2% | ||
| Q1 24 | 5.8% | -4.8% |
每股收益（稀释后）DCGOPIII
| Q4 25 | $-1.36 | $-23.08 | ||
| Q3 25 | $-0.28 | $-9.67 | ||
| Q2 25 | $-0.11 | $-6.23 | ||
| Q1 25 | $-0.09 | $-6.28 | ||
| Q4 24 | $-0.03 | $-23.13 | ||
| Q3 24 | $0.05 | $-15.70 | ||
| Q2 24 | $0.06 | $-7.37 | ||
| Q1 24 | $0.10 | $-7.86 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $51.0M | $25.0M |
| 总债务越低越好 | $235.6K | $228.4M |
| 股东权益账面价值 | $144.0M | $-155.2M |
| 总资产 | $217.1M | $656.6M |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
现金及短期投资DCGOPIII
| Q4 25 | $51.0M | $25.0M | ||
| Q3 25 | $73.4M | $37.7M | ||
| Q2 25 | $104.2M | $38.6M | ||
| Q1 25 | $79.0M | $40.1M | ||
| Q4 24 | $89.2M | $38.8M | ||
| Q3 24 | $89.5M | $63.0M | ||
| Q2 24 | $66.1M | $73.1M | ||
| Q1 24 | $41.2M | $27.3M |
总债务DCGOPIII
| Q4 25 | $235.6K | $228.4M | ||
| Q3 25 | $249.9K | $252.8M | ||
| Q2 25 | $12.6K | $182.0M | ||
| Q1 25 | $15.1K | $171.1M | ||
| Q4 24 | $17.7K | $108.9M | ||
| Q3 24 | $47.7K | $133.2M | ||
| Q2 24 | $52.8K | $133.1M | ||
| Q1 24 | $60.1K | $118.1M |
股东权益DCGOPIII
| Q4 25 | $144.0M | $-155.2M | ||
| Q3 25 | $270.5M | $-18.7M | ||
| Q2 25 | $297.3M | $44.5M | ||
| Q1 25 | $309.3M | $63.3M | ||
| Q4 24 | $320.9M | $75.9M | ||
| Q3 24 | $325.2M | $120.5M | ||
| Q2 24 | $315.2M | $166.8M | ||
| Q1 24 | $311.3M | $146.6M |
总资产DCGOPIII
| Q4 25 | $217.1M | $656.6M | ||
| Q3 25 | $353.8M | $683.6M | ||
| Q2 25 | $408.3M | $731.6M | ||
| Q1 25 | $430.8M | $783.9M | ||
| Q4 24 | $455.6M | $783.4M | ||
| Q3 24 | $493.9M | $833.3M | ||
| Q2 24 | $488.2M | $892.8M | ||
| Q1 24 | $490.7M | $855.9M |
负债/权益比DCGOPIII
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | 4.09× | ||
| Q1 25 | 0.00× | 2.71× | ||
| Q4 24 | 0.00× | 1.43× | ||
| Q3 24 | 0.00× | 1.11× | ||
| Q2 24 | 0.00× | 0.80× | ||
| Q1 24 | 0.00× | 0.81× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-10.5M | $-25.7M |
| 自由现金流经营现金流 - 资本支出 | $-12.0M | — |
| 自由现金流率自由现金流/营收 | -16.0% | — |
| 资本支出强度资本支出/营收 | 2.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $29.9M | — |
8季度趋势，按日历期对齐
经营现金流DCGOPIII
| Q4 25 | $-10.5M | $-25.7M | ||
| Q3 25 | $1.7M | $-15.4M | ||
| Q2 25 | $33.6M | $-16.6M | ||
| Q1 25 | $9.7M | $-33.5M | ||
| Q4 24 | $12.7M | $-57.2M | ||
| Q3 24 | $31.1M | $-22.6M | ||
| Q2 24 | $36.9M | $-10.2M | ||
| Q1 24 | $-10.6M | $-20.0M |
自由现金流DCGOPIII
| Q4 25 | $-12.0M | — | ||
| Q3 25 | $782.6K | — | ||
| Q2 25 | $32.9M | — | ||
| Q1 25 | $8.2M | — | ||
| Q4 24 | $12.0M | — | ||
| Q3 24 | $30.2M | — | ||
| Q2 24 | $35.9M | — | ||
| Q1 24 | $-11.6M | — |
自由现金流率DCGOPIII
| Q4 25 | -16.0% | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | 40.9% | — | ||
| Q1 25 | 8.5% | — | ||
| Q4 24 | 9.9% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | 21.7% | — | ||
| Q1 24 | -6.0% | — |
资本支出强度DCGOPIII
| Q4 25 | 2.0% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 1.5% | — | ||
| Q4 24 | 0.6% | 0.0% | ||
| Q3 24 | 0.7% | 0.0% | ||
| Q2 24 | 0.6% | 0.0% | ||
| Q1 24 | 0.5% | 0.0% |
现金转化率DCGOPIII
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.67× | — | ||
| Q2 24 | 5.65× | — | ||
| Q1 24 | -0.95× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DCGO
| Transportation Services Segment | $50.2M | 67% |
| Mobile Health Services Segment | $24.8M | 33% |
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
